
Novel CCR4 антагонист, enhancing DC activation and homing to the regional lymph node and showing мощный vaccine adjuvant activity through the inhibition of regulatory T-клетка recruitment
Novel CCR4 antagonist, enhancing DC activation and homing to the regional lymph node and showing potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.